Spinocerebellar ataxia type 2 with levodopa‐responsive parkinsonism culminating in motor neuron disease
- 17 March 2004
- journal article
- case report
- Published by Wiley in Movement Disorders
- Vol. 19 (7) , 848-852
- https://doi.org/10.1002/mds.20090
Abstract
We describe an exceptional spinocerebellar ataxia type 2 (SCA2) phenotype combining cerebellar ataxia, levodopa‐responsive parkinsonism, and motor neuron symptoms. We conclude that motor neuron symptoms and signs may be a striking manifestation in SCA2, masking pre‐existing cerebellar and extrapyramidal semeiology. © 2004 Movement Disorder SocietyKeywords
Funding Information
- Investigación en Red de las Enfermedades Neurológicas (CO3/06)
- Fondo de Investigación Sanitaria (02/0027)
This publication has 30 references indexed in Scilit:
- Early or late appearance of "dropped head syndrome" in amyotrophic lateral sclerosisJournal of Neurology, Neurosurgery & Psychiatry, 2003
- Presynaptic parkinsonism in multiple system atrophy mimicking Parkinson's disease: A clinicopathological case studyMovement Disorders, 2002
- Dopa‐responsive parkinsonism phenotype of spinocerebellar ataxia type 2Movement Disorders, 2002
- Spinocerebellar ataxias in Spanish patients: genetic analysis of familial and sporadic casesHuman Genetics, 1999
- The role of the SCA2 trinucleotide repeat expansion in 89 autosomal dominant cerebellar ataxia families. Frequency, clinical and genetic correlatesBrain, 1998
- Identification of the spinocerebellar ataxia type 2 gene using a direct identification of repeat expansion and cloning technique, DIRECTNature Genetics, 1996
- Moderate expansion of a normally biallelic trinucleotide repeat in spinocerebellar ataxia type 2Nature Genetics, 1996
- Autosomal dominant cerebellar ataxia type I in Martinique (French West Indies)Brain, 1995
- Clinical features and natural history of multiple system atrophyBrain, 1994
- Presynaptic parkinsonism in olivopontocerebellar atrophy: Clinical, pathological, and neurochemical evidenceAnnals of Neurology, 1991